Details
|
Pharmacyclics, inc., is a pharmaceutical company, which is developing drugs for the treatment of atherosclerosis, cancer, and other diseases. Pharmacyclics is offering an anti-cancer agent, called Xcytrin which is indicated for targeting cancer cell and, by disrupting metabolism of cell, inducing death of cell through a cellular process, called apoptosis. Pharmacyclics,inc. is also developing Antrin angiophtotherapy,which already completed Phase 1 critical study, which is indicated for treatments of atherosclerosis involving heart's coronary arteries. The company was co-founded by Richard Miller in 1991 and is located in Sunnyvale, state California. Contact www. pharmacyclics.com. Tel# 408-774-0330. Pharmacylics is a company traded on the Nasdaq Exchange under symbol: PCYC.
|
